Vol 2 (June 25, 2024): AME Clinical Trials Review

Improving the efficacy of immunotherapy in patients with advanced or metastatic urothelial carcinoma: a new role for tyrosine kinase inhibitors in the treatment paradigm?

Hyperthermic intraperitoneal chemotherapy in colorectal cancer: is COLOPEC just another brick in the wall?

Targeting TIGIT in lung cancer: will it stick to the wall?

Yes to adjuvant osimertinib therapy in EGFR-mutated stage IB–IIIA non-small cell lung cancer post resection, but for how long? (ADAURA/NCT02511106)

Second-line nivolumab with paclitaxel in biomarker-enriched gastric cancer: not all biomarkers are created equal but is the question even relevant anymore?

Advancing neoadjuvant immunotherapy in non-small cell lung cancer (NSCLC): commentary on the Lung Cancer Mutation Consortium 3 trial (LCMC3)

Judicious use of coronary computed tomography angiography reduces major procedure-related complications in patients aged <65 years with stable chest pain

Prostate-specific membrane antigen (PSMA) radio-guided surgery in prostate cancer: expanding the spectrum of tracers and technologies for patient-tailored molecular-guided surgery

Induction therapy for acute myeloid leukemia: still nothing beyond 7+3?

The Butterfly effect—will the MARIPOSA-2 study alter the trajectory of EGFR mutated non-small cell lung cancer (NSCLC)

Ripretinib as a second-line therapy for advanced gastrointestinal stromal tumors in the era of precision medicine

KEYNOTE-189 5-years update: setting a backbone for the next generation clinical research in advanced non-squamous non-small cell lung cancer without oncogenic addiction

Preventing skeletal related events with radiation therapy in cancer patients with bone metastases

YK-029A in the landscape of treatments for non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations

The future of EGFR exon 20 targeting in non-small cell lung cancer

Is atezolizumab plus bevacizumab with chemotherapy effective for non-small cell lung cancer with EGFR- or ALK-alteration?